SomaLogic
SomaLogic is fostering the discovery of effective and safer treatments for patients while empowering more accurate diagnosis, prevention and treatment of disease through the next generation of proteomics.
Latest SomaLogic Content
Webinar
Young Blood for Old Brains: The Quest to Slow Brain Aging
On-Demand
Recent technological progress has allowed biologists to measure an unprecedented number of these molecules throughout an organism, providing unique insights into the physiological and pathological conditions of cells and organs, including the aging
Whitepaper
Identifying Protein Biomarkers for Aging Research
This whitepaper explores innovative proteomic tools that offer insights into protein signatures and that can serve as biomarkers for aging.
Infographic
How Proteomics Is Transforming Aging Research
This infographic explores how a protein detection assay – which outperforms antibody-based proteomics approaches – can unlock crucial insights for developing targeted treatments and enhancing our understanding of aging and disease progression.
Webinar
Scaling Proteomics: Balancing Performance and Measuring Enough Proteins
On-Demand
As proteomics platforms have advanced, the number of proteins measured and sample throughput have dramatically increased. However, have sacrifices or trade-offs been necessary to make these gains?
Webinar
Using Proteomics To Advance Understanding of Alzheimer’s Disease
On-Demand
In this webinar, we’ll explore how integrating proteomics with systems biology sheds light on the complexities of AD pathology.
Product
Advertisement
SomaScan® 11K Assay Services: Unparallelled Protein Content for High-Plex Protein Profiling and Biomarker Discovery
Introducing the SomaScan® 11K Assay – Pioneering proteomics. SomaLogic's high-plex, high throughput assay covers half the human proteome, empowering researchers to identify unique pathway and protein signatures. Explore the power of more.
Webinar
Identifying Biomarkers for IBD Diagnosis and Management
On-Demand
Driving biomarker discovery is key as proteomics emerges as the next frontier in precision medicine.
In this webinar, you’ll hear how proteomics technology can enhance the identification of biomarkers for the accurate diagnosis of Crohn’s disease and ulcerative colitis, as well as the identification of biomarkers that predict response to TNF inhibitors and other biologics in patients with IBD.
This webinar will explore how reliable, non-invasive proteomic biomarkers are pivotal for personalized treatment and increasing our knowledge of biological pathways involved in disease. Our expert speaker will also present an assay platform that can measure 11,000 biologically relevant proteins in the search for biomarkers.
In this webinar, you’ll hear how proteomics technology can enhance the identification of biomarkers for the accurate diagnosis of Crohn’s disease and ulcerative colitis, as well as the identification of biomarkers that predict response to TNF inhibitors and other biologics in patients with IBD.
This webinar will explore how reliable, non-invasive proteomic biomarkers are pivotal for personalized treatment and increasing our knowledge of biological pathways involved in disease. Our expert speaker will also present an assay platform that can measure 11,000 biologically relevant proteins in the search for biomarkers.
Product News
OncoHost To Present Proteomics-Based Predictive Biomarker for Immune-Related Adverse Events in NSCLC Patients
Novel computational model accurately predicts significant irAEs in NSCLC patients based on proteomic profiling of one pre-treatment blood test.
Webinar
Using Plasma Proteomics To Understand Alzheimer’s and Other Brain Diseases
On-Demand
Dr. Walker will discuss how he integrates proteomic, genetic, brain imaging and cerebral spinal fluid biomarkers from initially cognitively normal individuals who later develop dementia, in order to discover novel blood-based biomarkers and mechanistically relevant proteins for therapeutic target prioritization.
Infographic
High-Throughput Protein Profiling: Discover New Disease Biomarkers
While most protein assays excel in one or two areas, the SomaScan Assay is the first and only platform that can measure 7,000 proteins from a 55-µL sample – covering more biological pathways than any other proteomic assay.
Advertisement